A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma

被引：0
|
作者：
Oladapo Yeku
Andrea L. Russo
Hang Lee
David Spriggs
机构：
[1] Harvard Medical School,Division of Hematology
[2] Massachusetts General Hospital,Oncology, Department of Medicine
[3] Harvard Medical School,Department of Radiation Oncology
[4] Massachusetts General Hospital,Biostatistics Center
[5] Harvard Medical School,undefined
[6] Massachusetts General Hospital,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
Vulvar cancer; Pembrolizumab; Chemoradiation; Immunotherapy; Chemoimmunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] UNRESECTABLE NONMETASTATIC SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS MANAGED BY SEQUENTIAL CHEMOTHERAPY (CISPLATIN AND BLEOMYCIN) AND RADIATION-THERAPY
    IZQUIERDO, MA
    MARCUELLO, E
    DESEGURA, GG
    BLANCO, R
    CANALS, E
    GOMEZ, A
    SAMPEDRO, F
    CANCER, 1993, 71 (02) : 287 - 292
  • [42] Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN.
    Maubec, Eve
    Boubaya, Marouane
    Petrow, Peter
    Basset-Seguin, Nicole
    Grob, Jean Jacques
    Dreno, Brigitte
    Beylot-Barry, Marie
    Scheer-Senyarich, Isabelle
    Helfen, Sabine
    Leccia, Marie Therese
    Stefan, Andreea Raluca
    Saiag, Philippe
    De Quatrebarbes, Julie
    Meyer, Nicolas
    Deschamps, Lydia
    Alloux, Celine
    Lopez, Isabelle
    Cherbal, Soufian
    Tibi, Annick
    Levy, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Topical chemo-immunotherapy converts a pro-tumorigenic tumor microenvironment to a pro-inflammatory phenotype in human cutaneous squamous cell carcinoma
    Friedman, Blake
    Carey, Cara
    Erdos, Geza
    Falo, Louis D.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [44] Concurrent chemo-irradiation with weekly cisplatin and paclitaxel in the treatment of locally advanced squamous cell carcinoma of cervix: A phase II study
    Varghese, Sunitha Susan
    Ram, Thomas Samuel
    Pavamani, Simon Pradeep
    Thomas, Elsa Mary
    Jeyaseelan, Visalakshi
    Viswanathan, Peringulam Narayan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (02) : 330 - 336
  • [45] Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Hellwig, Konstantin
    Ellmann, Stephan
    Eckstein, Markus
    Wiesmueller, Marco
    Rutzner, Sandra
    Semrau, Sabine
    Frey, Benjamin
    Gaipl, Udo S.
    Gostian, Antoniu Oreste
    Hartmann, Arndt
    Iro, Heinrich
    Fietkau, Rainer
    Uder, Michael
    Hecht, Markus
    Baeuerle, Tobias
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study
    Hu, Hui-Hui
    Xu, Xin
    Li, Xiao-Yang
    Zeng, Ya
    Li, Yue
    Song, Xin-Yun
    Fu, Xiao-Long
    Ma, Xiu-Mei
    Yu, Wen
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 48
  • [47] Phase 2 study of pembrolizumab plus lenvatinib and belzutifan in patients with metastatic esophageal squamous cell carcinoma.
    Rojas, Carlos
    Ryoo, Baek-Yeol
    Rha, Sun Young
    Kelley, Robin Kate
    Hubert, Ayala
    Painemal, Claudio
    Wadlow, Raymond Couric
    Gong, Jun
    Fan, Li
    Jin, Fan
    Naik, Girish S.
    Macarulla, Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS425 - TPS425
  • [48] Docetaxel/TS-1 with Radiation for Unresectable Squamous Cell Carcinoma of the Esophagus - A Phase II Trial
    Matsumoto, Hideo
    Kubota, Hisako
    Higashida, Masaharu
    Yoden, Eisaku
    Hiratsuka, Junichi
    Haruma, Ken
    Nakamura, Masafumi
    Hirai, Toshihiro
    ANTICANCER RESEARCH, 2014, 34 (07) : 3759 - 3763
  • [49] Phase II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Herchenhorn, D.
    Dias, F. L.
    Pineda, R. M.
    Fonseca, A. J.
    Bezerra, M.
    Ferreira, C. G.
    Knust, R. E.
    Fontao, K.
    Martins, R. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma
    Susumu Nakahara
    Yukinori Takenaka
    Kazuhiko Ogawa
    Suetaka Nishiike
    Yoshifumi Yamamoto
    Yuji Seo
    Fumiaki Isohashi
    Osamu Suzuki
    Yasuo Yoshioka
    Iori Sumida
    Tadashi Yoshii
    Yoichiro Tomiyama
    Hidenori Inohara
    International Journal of Clinical Oncology, 2016, 21 : 1030 - 1037
12345